PDYN and Parkinson disease: Using a newly established liquid chromatography−tandem mass spectrometry (LC–MS/MS) method in multiple reaction monitoring mode (MRM), we previously showed decreased cerebrospinal fluid (CSF) PDYN-derived peptide levels in HD and a tendency towards reduced levels in PD patients [8].